SCHEDULE 13G/A

Supernus Pharmaceuticals Inc

Common Stock, par value $0.001 per share · CUSIP: 868459108

Event date: 2026-02-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Integrated Core Strategies (US) LLC

  Shares: 2,817,883.00 · Class: 4.9%

• Millennium Management LLC

  Shares: 3,281,615.00 · Class: 5.7%

• Millennium Group Management LLC

  Shares: 3,281,615.00 · Class: 5.7%

• Israel A. Englander

  Shares: 3,281,615.00 · Class: 5.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.